INVENTS PEG: innovative methodologies for paediatric research

INVENTS PEG: innovative methodologies for paediatric research

On 2 and 3 November 2024, the first face-to-face meeting of the INVENTS Paediatric Patient Expert Group (PEG) titled “Innovative methodologies based on in silico models and the secondary use of health data” was held in Bari. Under the European INVENTS project, TEDDY network, partner of the project, has established a PEG to support the researchers participating in this EU project with their opinions and suggestions to improve the conditions of thousands of children...
ICH E11A guideline on paediatric extrapolation reaches step 5

ICH E11A guideline on paediatric extrapolation reaches step 5

The ICH E11A Guideline on paediatric extrapolation reached Step 5 on 21 August 2024, following the public consultation of its draft version in 2022. The primary aim of this guideline is to promote the international harmonisation of paediatric extrapolation to support the development and authorisation of paediatric medicines. To achieve this goal, the guideline provides a framework of recommendations for applying extrapolation in paediatric drug development. This...
Adoption of the 10th revision of the Declaration of Helsinki

Adoption of the 10th revision of the Declaration of Helsinki

On 19 October 2024 the World Medical Association (WMA) adopted the 10th revision of the Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Participants. This is likely the most significant revision of the Declaration since 2000, as it reflects a determined effort to adapt ethical standards to contemporary challenges in medical research. The major revisions focus on: • Participant-centred respect and protection: this includes...
EMA’s final reflection paper on AI in medicinal products lifecycle

EMA’s final reflection paper on AI in medicinal products lifecycle

The European Medicines Agency (EMA) has officially released its final "Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle" following a public consultation period. This paper explores the potential applications and regulatory considerations for AI across the lifecycle of medicinal products, from drug discovery and clinical trials to post-authorisation activities such as pharmacovigilance. Notably, the reflection paper...
Nobel Prize for microRNAs discovery in gene regulation

Nobel Prize for microRNAs discovery in gene regulation

This year's Nobel Prize in Medicine has been awarded to two American researchers: Dr. Victor Ambros and Dr. Gary Ruvkun, who discovered microRNAs (miRNAs), a new class of small RNA molecules that play a crucial role in gene regulation. Ambros and Ruvkun's discovery revealed a new principle of gene regulation that is fundamental to multicellular organisms, including humans. Now we know that the human genome contains more than a thousand miRNAs, which play an...
EU HTA regulation: boosting collaboration and guidance

EU HTA regulation: boosting collaboration and guidance

The European Commission has published a draft Regulation on Health Technology Assessment (HTA), focusing on joint scientific consultations for medicinal products for human use and how developers can receive early guidance on the evidence and data needed to carry out a joint clinical assessment of their product. This initiative aims to enhance collaboration between EU Member States to assess new health technologies and provide guidance to developers, facilitating...

Subscribe To Our Newsletter

to keep you up to date on our activities and initiatives

La tua iscrizione non può essere convalidata.
La tua iscrizione è avvenuta correttamente.

We use Brevo as our marketing platform. By clicking below to submit this form, you are aware and accept that the information you have provided will be transferred to Brevo for treatment in accordance with their terms of use
Utilizziamo Brevo come nostra piattaforma di marketing. Cliccando qui sotto per inviare questo modulo, sei consapevole e accetti che le informazioni che hai fornito verranno trasferite a Brevo per il trattamento conformemente alle loro condizioni d'uso

You have Successfully Subscribed!